Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting.
The effect of carotid endarterectomy (CEA) and carotid artery stenting (CAS) on visual function has not been a specific end-point of most trials comparing CAS and CEA. Ischaemic lesions of the retina and optic nerve have been reported to occur in 15-46% of carotid patients, while carotid artery sten...
Main Authors: | , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2014
|
_version_ | 1797074431220121600 |
---|---|
author | Giannoukas, A Paraskevas, K Bulbulia, R Halliday, A |
author_facet | Giannoukas, A Paraskevas, K Bulbulia, R Halliday, A |
author_sort | Giannoukas, A |
collection | OXFORD |
description | The effect of carotid endarterectomy (CEA) and carotid artery stenting (CAS) on visual function has not been a specific end-point of most trials comparing CAS and CEA. Ischaemic lesions of the retina and optic nerve have been reported to occur in 15-46% of carotid patients, while carotid artery stenosis significantly reduces blood flow to the eye and orbit, resulting in the ocular ischaemic syndrome. |
first_indexed | 2024-03-06T23:36:03Z |
format | Journal article |
id | oxford-uuid:6db1cfe2-3bb3-4de9-8758-dae92ea6d0bd |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T23:36:03Z |
publishDate | 2014 |
publisher | Elsevier |
record_format | dspace |
spelling | oxford-uuid:6db1cfe2-3bb3-4de9-8758-dae92ea6d0bd2022-03-26T19:19:25ZOcular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6db1cfe2-3bb3-4de9-8758-dae92ea6d0bdEnglishSymplectic Elements at OxfordElsevier2014Giannoukas, AParaskevas, KBulbulia, RHalliday, AThe effect of carotid endarterectomy (CEA) and carotid artery stenting (CAS) on visual function has not been a specific end-point of most trials comparing CAS and CEA. Ischaemic lesions of the retina and optic nerve have been reported to occur in 15-46% of carotid patients, while carotid artery stenosis significantly reduces blood flow to the eye and orbit, resulting in the ocular ischaemic syndrome. |
spellingShingle | Giannoukas, A Paraskevas, K Bulbulia, R Halliday, A Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting. |
title | Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting. |
title_full | Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting. |
title_fullStr | Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting. |
title_full_unstemmed | Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting. |
title_short | Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting. |
title_sort | ocular defects as surrogate end points in trials comparing carotid endarterectomy and stenting |
work_keys_str_mv | AT giannoukasa oculardefectsassurrogateendpointsintrialscomparingcarotidendarterectomyandstenting AT paraskevask oculardefectsassurrogateendpointsintrialscomparingcarotidendarterectomyandstenting AT bulbuliar oculardefectsassurrogateendpointsintrialscomparingcarotidendarterectomyandstenting AT hallidaya oculardefectsassurrogateendpointsintrialscomparingcarotidendarterectomyandstenting |